Newly known group of stat3 signaling pathway inhibitors and cancer stem cell inhibitors
- 专利权人:
- Boston Biomedical; Inc.
- 发明人:
- JIANG, Zhiwei,LI, Chiang, Jia,LI, Wei,LEGGETT, David
- 申请号：
- DK08830471
- 公开号：
- DK2194987T3
- 申请日:
- 2008.09.10
- 申请国别(地区):
- DK
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to the composition and methods of use of Stat3 pathway inhibitors or cancer stem cell inhibitors in combination treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- DRUG MADE FROM STEM CELLS WITH REPROGRAMMED CELL SIGNALING, METHOD FOR PRODUCING SAID PREPARATION AND THE USE THEREOF
- Production method of retinal pigment epithelial cells
- Wnt signaling inhibitors, and methods for making and using them
- Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising Wnt signaling pathway activators
- Method for producing retinal pigment epithelial cells
